Twist Bioscience Corporation

the TWIS Biosciences Fiscal 2023 First Quarter Financial Results Conference Call. At this time, all participants are in listen-only mode. After the speaker's prepared remarks, we will conduct a question and answer session. Instructions will be given at that time. As a reminder, this call may be recorded. I would like to turn the call over to Angela Bidding, Senior Vice President of Corporate Affairs and Chief ESG Officer.

Thank you, Operator. Good morning, everyone.

I would like to thank all of you for joining us today for the TWIST Bioscience Conference Call to review our fiscal 2023 first quarter financial results and business progress. We issued our financial results release this morning, which is available at our website at www.twistbioscience.com. With me on today's call are Dr. Emily Lipprust, CEO and co-founder of TWIST, and Jim Thorburn, CFO of TWIST. Emily will begin with a review of our recent progress on TWIS businesses. Jim will report on our financial and operational performance. Emily will come back to discuss our upcoming milestones and directions, and then we'll open the call for questions. We would ask that you limit your questions to a maximum of two and then re-queue as a courtesy to others on the call. As a reminder, this call is being recorded. The audio portion will be archived in the investor section of our website and will be available for two weeks. During today's presentation, we will be making forward-looking statements within the meaning of the U.S.